Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2013

Open Access 01-12-2013 | Research article

Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis

Authors: Maria M Wertli, Katrin B Ruchti, Johann Steurer, Ulrike Held

Published in: BMC Medicine | Issue 1/2013

Login to get access

Abstract

Background

Non-cardiovascular chest pain (NCCP) has a high healthcare cost, but insufficient guidelines exist for its diagnostic investigation. The objective of the present work was to identify important diagnostic indicators and their accuracy for specific and non-specific conditions underlying NCCP.

Methods

A systematic review and meta-analysis were performed. In May 2012, six databases were searched. Hand and bibliography searches were also conducted. Studies evaluating a diagnostic test against a reference test in patients with NCCP were included. Exclusion criteria were having <30 patients per group, and evaluating diagnostic tests for acute cardiovascular disease. Diagnostic accuracy is given in likelihood ratios (LR): very good (LR+ >10, LR- <0.1); good (LR + 5 to 10, LR- 0.1 to 0.2); fair (LR + 2 to 5, LR- 0.2 to 0.5); or poor (LR + 1 to 2, LR- 0.5 to 1). Joined meta-analysis of the diagnostic test sensitivity and specificity was performed by applying a hierarchical Bayesian model.

Results

Out of 6,316 records, 260 were reviewed in full text, and 28 were included: 20 investigating gastroesophageal reflux disorders (GERD), 3 musculoskeletal chest pain, and 5 psychiatric conditions. Study quality was good in 15 studies and moderate in 13. GERD diagnosis was more likely with typical GERD symptoms (LR + 2.70 and 2.75, LR- 0.42 and 0.78) than atypical GERD symptoms (LR + 0.49, LR- 2.71). GERD was also more likely with a positive response to a proton pump inhibitor (PPI) test (LR + 5.48, 7.13, and 8.56; LR- 0.24, 0.25, and 0.28); the posterior mean sensitivity and specificity of six studies were 0.89 (95% credible interval, 0.28 to 1) and 0.88 (95% credible interval, 0.26 to 1), respectively. Panic and anxiety screening scores can identify individuals requiring further testing for anxiety or panic disorders. Clinical findings in musculoskeletal pain either had a fair to moderate LR + and a poor LR- or vice versa.

Conclusions

In patients with NCCP, thorough clinical evaluation of the patient’s history, symptoms, and clinical findings can indicate the most appropriate diagnostic tests. Treatment response to high-dose PPI treatment provides important information regarding GERD, and should be considered early. Panic and anxiety disorders are often undiagnosed and should be considered in the differential diagnosis of chest pain.
Appendix
Available only for authorised users
Literature
1.
Eslick GD, Coulshed DS, Talley NJ: Review article: the burden of illness of non-cardiac chest pain. Aliment Pharmacol Ther. 2002, 16: 1217-1223. 10.1046/j.1365-2036.2002.01296.x.CrossRefPubMed
2.
Kahn SE: The challenge of evaluating the patient with chest pain. Arch Pathol Lab Med. 2000, 124: 1418-1419.PubMed
3.
Cayley WE: Diagnosing the cause of chest pain. Am Fam Physician. 2005, 72: 2012-2021.PubMed
4.
Blatchford O, Capewell S, Murray S, Blatchford M: Emergency medical admissions in Glasgow: general practices vary despite adjustment for age, sex, and deprivation. Brit J Gen Pract. 1999, 49: 551-554.
5.
Pope JH, Aufderheide TP, Ruthazer R, Woolard RH, Feldman JA, Beshansky JR, Griffith JL, Selker HP: Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000, 342: 1163-1170. 10.1056/NEJM200004203421603.CrossRefPubMed
6.
Buntinx F, Knockaert D, Bruyninckx R, De Blaey N, Aerts M, Knottnerus JA, Delooz H: Chest pain in general practice or in the hospital emergency department: is it the same?. Fam Pract. 2001, 18: 586-589. 10.1093/fampra/18.6.586.CrossRefPubMed
7.
Ruddox V, Mathisen M, Otterstad JE: Prevalence and prognosis of non-specific chest pain among patients hospitalized for suspected acute coronary syndrome - a systematic literature search. BMC Med. 2012, 10: 58-10.1186/1741-7015-10-58.CrossRefPubMedPubMedCentral
8.
Nilsson S, Scheike M, Engblom D, Karlsson LG, Molstad S, Akerlind I, Ortoft K, Nylander E: Chest pain and ischaemic heart disease in primary care. Brit J Gen Pract. 2003, 53: 378-382.
9.
Verdon F, Burnand B, Herzig L, Junod M, Pecoud A, Favrat B: Chest wall syndrome among primary care patients: a cohort study. BMC Fam Pract. 2007, 8: 51-10.1186/1471-2296-8-51.CrossRefPubMedPubMedCentral
10.
Svavarsdottir AE, Jonasson MR, Gudmundsson GH, Fjeldsted K: Chest pain in family practice. Diagnosis and long-term outcome in a community setting. Can Fam Physician. 1996, 42: 1122-1128.PubMed
11.
Eslick GD, Talley NJ: Natural history and predictors of outcome for non-cardiac chest pain: a prospective 4-year cohort study. Neurogastroenterol Motil. 2008, 20: 989-997. 10.1111/j.1365-2982.2008.01133.x.CrossRefPubMed
12.
Eslick GD, Talley NJ: Non-cardiac chest pain: predictors of health care seeking, the types of health care professional consulted, work absenteeism and interruption of daily activities. Aliment Pharmacol Ther. 2004, 20: 909-915. 10.1111/j.1365-2036.2004.02175.x.CrossRefPubMed
13.
Stochkendahl MJ, Christensen HW: Chest pain in focal musculoskeletal disorders. Med Clin North Am. 2010, 94: 259-273. 10.1016/j.mcna.2010.01.007.CrossRefPubMed
14.
Katz PO: Approach to the patient with unexplained chest pain. Semin Gastrointest Dis. 2001, 12: 38-45.PubMed
15.
Whiting P, Rutjes AW, Dinnes J, Reitsma J, Bossuyt PM, Kleijnen J: Development and validation of methods for assessing the quality of diagnostic accuracy studies. Health Technol Assess. 2004, 8: iii-1–234CrossRefPubMed
16.
Maev IV, Iurenev GL, Burkov SG, V’Iuchnova ES: Rabeprazole test and comparison of the effectiveness of course treatment with rabeprazole in patients with gastroesophageal reflux disease and non-coronary chest pain. Klin Med. 2007, 85: 45-51.
17.
Bachmann LM, Puhan MA, Riet G, Bossuyt PM: Sample sizes of studies on diagnostic accuracy: literature survey. BMJ Clin Res Ed. 2006, 332: 1127-1129. 10.1136/bmj.38793.637789.2F.CrossRef
18.
Carley S, Dosman S, Jones SR, Harrison M: Simple nomograms to calculate sample size in diagnostic studies. Emerg Med J. 2005, 22: 180-181. 10.1136/emj.2003.011148.CrossRefPubMedPubMedCentral
19.
20.
Jaeschke R: Users’ guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group. JAMA. 1994, 271: 703-707. 10.1001/jama.1994.03510330081039.CrossRefPubMed
21.
Rutter CM, Gatsonis CA: A hierarchical regression approach to meta-analysis of diagnostic test accuracy evaluations. Stat Med. 2001, 20: 2865-2884. 10.1002/sim.942.CrossRefPubMed
22.
23.
Schiller I, Dendukuri N: HSROC: Joint meta-analysis of diagnostic test sensitivity and specificity with or without a gold standard reference test. R package version 2.1.6. 2013
24.
Kim JH, Rhee PL, Park EH, Son HJ, Kim JJ, Rhee JC: Clinical usefulness of subgrouping of patients with non-cardiac chest pain according to characteristic symptoms in Korea. J Gastroenterol Hepatol. 2007, 22: 320-325. 10.1111/j.1440-1746.2006.04264.x.CrossRefPubMed
25.
Hong SN, Rhee PL, Kim JH, Lee JH, Kim YH, Kim JJ, Rhee JC: Does this patient have oesophageal motility abnormality or pathological acid reflux?. Dig Liver Dis. 2005, 37: 475-484. 10.1016/j.dld.2005.01.018.CrossRefPubMed
26.
Netzer P, Gut A, Heer R, Gries N, Pfister M, Halter F, Inauen W: Five-year audit of ambulatory 24-hour esophageal pH-manometry in clinical practice. Scand J Gastroenterol. 1999, 34: 676-682. 10.1080/003655299750025877.CrossRefPubMed
27.
Mousavi S, Tosi J, Eskandarian R, Zahmatkesh M: Role of clinical presentation in diagnosing reflux-related non-cardiac chest pain. J Gastroenterol Hepatol. 2007, 22: 218-221. 10.1111/j.1440-1746.2006.04416.x.CrossRefPubMed
28.
Singh S, Richter JE, Bradley LA, Haile JM: The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993, 38: 1402-1408. 10.1007/BF01308595.CrossRefPubMed
29.
Ho K: Gastroesophageal reflux disease is a common cause of non-cardiac chest pain in a country with a low prevalence ofreflux esophagitis. Dig Dis Sci. 1998, 43: 1991-1997. 10.1023/A:1018842811123.CrossRefPubMed
30.
Lam HGT: Acute non-cardiac chest pain in a coronary care unit: evaluation by 24-hour pressure and pH recording of the esophagus. Gastroenterology. 1992, 102: 453-460.CrossRefPubMed
31.
Dickman R, Emmons S, Cui H, Sewell J, Hernandez D, Esquivel RF, Fass R: The effect of a therapeutic trial of high-dose rabeprazole on symptom response of patients with non-cardiac chest pain: a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2005, 22: 547-555. 10.1111/j.1365-2036.2005.02620.x.CrossRefPubMed
32.
Bautista J, Fullerton H, Briseno M, Cui H, Fass R: The effect of an empirical trial of high-dose lansoprazole on symptom response of patients with non-cardiac chest pain - a randomized, double-blind, placebo-controlled, crossover trial. Aliment Pharmacol Ther. 2004, 19: 1123-1130. 10.1111/j.1365-2036.2004.01941.x.CrossRefPubMed
33.
Fass R, Fennerty MB, Ofman JJ, Gralnek IM, Johnson C, Camargo E, Sampliner RE: The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology. 1998, 115: 42-49. 10.1016/S0016-5085(98)70363-4.CrossRefPubMed
34.
Pandak WM, Arezo S, Everett S, Jesse R, DeCosta G, Crofts T, Gennings C, Siuta M, Zfass A: Short course of omeprazole - A better first diagnostic approach to noncardiac chest pain than endoscopy, manometry, or 24-hour esophageal pH monitoring. J Clin Gastroenterol. 2002, 35: 307-314. 10.1097/00004836-200210000-00006.CrossRefPubMed
35.
Kim JH, Sinn DH, Son HJ, Kim JJ, Rhee JC, Rhee PL: Comparison of one-week and two-week empirical trial with a high-dose rabeprazole in non-cardiac chest pain patients. J Gastroenterol Hepatol. 2009, 24: 1504-1509. 10.1111/j.1440-1746.2009.05859.x.CrossRefPubMed
36.
Xia HH, Lai KC, Lam SK, Hu WH, Wong NY, Hui WM, Lau CP, Chen WH, Chan CK, Wong WM, Wong BC: Symptomatic response to lansoprazole predicts abnormal acid reflux in endoscopy-negative patients with non-cardiac chest pain. Aliment Pharmacol Ther. 2003, 17: 369-377. 10.1046/j.1365-2036.2003.01436.x.CrossRefPubMed
37.
Kushnir VM, Sayuk GS, Gyawali CP: Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain. Am J Gastroenterol. 2010, 105: 1032-1038. 10.1038/ajg.2009.646.CrossRefPubMed
38.
Lacima G, Grande L, Pera M, Francino A, Ros E: Utility of ambulatory 24-hour esophageal pH and motility monitoring in noncardiac chest pain: report of 90 patients and review of the literature. Dig Dis Sci. 2003, 48: 952-961. 10.1023/A:1023011931955.CrossRefPubMed
39.
Cooke RA, Anggiansah A, Smeeton NC, Owen WJ, Chambers JB: Gastroesophageal reflux in patients with angiographically normal coronary-arteries - an uncommon cause of exertional chest pain. Br Heart J. 1994, 72: 231-236. 10.1136/hrt.72.3.231.CrossRefPubMedPubMedCentral
40.
Bovero E, Torre F, Poletti M, Faveto M, De Iaco F: Exertional gastroesophageal pH-metry: a new provocative physiological test in the diagnosis of chest pain. Gastroenterol Clin Biol. 1993, 17: 4-8.PubMed
41.
Romand F, Vincent E, Potier V, Claudel N, Galoo E, Desbaumes J: Angina-like chest pain and exertional esophageal pH monitoring. Gastroenterol Clin Biol. 1999, 23: 313-318.PubMed
42.
Abrahao LJ, Lemme EMO: Role of esophageal provocative tests in the investigation of patients with chest pain of undetermined origin [in Portugese]. Arq Gastroenterol. 2005, 42: 139-145.CrossRefPubMed
43.
Achem SR, Almansa C, Krishna M, Heckman MG, Wolfsen HC, Talley NJ, DeVault KR: Oesophageal eosinophilic infiltration in patients with noncardiac chest pain. Aliment Pharmacol Ther. 2011, 33: 1194-1201. 10.1111/j.1365-2036.2011.04652.x.CrossRefPubMed
44.
Stochkendahl MJ, Vach W, Hartvigsen J, Hoilund-Carlsen PF, Haghfelt T, Christensen HW: Reconstruction of the decision-making process in assessing musculoskeletal chest pain: an exploratory study using recursive partitioning. J Manipulative Physiol Ther. 2012, 35: 184-195. 10.1016/j.jmpt.2012.01.009.CrossRefPubMed
45.
Bosner S, Becker A, Hani MA, Keller H, Sonnichsen AC, Karatolios K, Schaefer JR, Haasenritter J, Baum E, Donner-Banzhoff N: Chest wall syndrome in primary care patients with chest pain: presentation, associated features and diagnosis. Fam Pract. 2010, 27: 363-369. 10.1093/fampra/cmq024.CrossRefPubMed
46.
Manchikanti L, Singh V, Pampati V, Beyer CD, Damron KS: Evaluation of the prevalence of facet joint pain in chronic thoracic pain. Pain Physician. 2002, 5: 354-359.PubMed
47.
Kuijpers PM, Denollet J, Lousberg R, Wellens HJ, Crijns H, Honig A: Validity of the hospital anxiety and depression scale for use with patients with noncardiac chest pain. Psychosomatics. 2003, 44: 329-335. 10.1176/appi.psy.44.4.329.CrossRefPubMed
48.
Demiryoguran NS, Karcioglu O, Topacoglu H, Kiyan S, Ozbay D, Onur E, Korkmaz T, Demir OF: Anxiety disorder in patients with non-specific chest pain in the emergency setting. Emerg Med J. 2006, 23: 99-102. 10.1136/emj.2005.025163.CrossRefPubMedPubMedCentral
49.
Foldes-Busque G, Fleet R, Poitras J, Chauny JM, Belleville G, Denis I, Diodati JG, Pelland ME, Lessard MJ, Marchand A: Preliminary investigation of the Panic Screening Score for emergency department patients with unexplained chest pain. Acad Emerg Med. 2011, 18: 322-325. 10.1111/j.1553-2712.2011.01009.x.CrossRefPubMed
50.
Fleet RP, Dupuis G, Marchand A, Burelle D, Beitman BD: Detecting panic disorder in emergency department chest pain patients: a validated model to improve recognition. Ann Behav Med. 1997, 19: 124-131. 10.1007/BF02883329.CrossRefPubMed
51.
Katerndahl DA, Trammell C: Prevalence and recognition of panic states in STARNET patients presenting with chest pain. J Fam Pract. 1997, 45: 54-63.PubMed
52.
Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, Johnson F, Hongo M, Richter JE, Spechler SJ, Tytgat GN, Wallin L: Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999, 45: 172-180. 10.1136/gut.45.2.172.CrossRefPubMedPubMedCentral
53.
Genta RM, Spechler SJ, Kielhorn AF: The Los Angeles and Savary-Miller systems for grading esophagitis: utilization and correlation with histology. Dis Esophagus. 2011, 24: 10-17. 10.1111/j.1442-2050.2010.01092.x.CrossRefPubMed
54.
Pandolfino JE, Vakil NB, Kahrilas PJ: Comparison of inter- and intraobserver consistency for grading of esophagitis by expert and trainee endoscopists. Gastrointest Endosc. 2002, 56: 639-643. 10.1016/S0016-5107(02)70110-7.CrossRefPubMed
55.
De Meester TR, Wang CI, Wernly JA, Pellegrini CA, Little AG, Klementschitsch P, Bermudez G, Johnson LF, Skinner DB: Technique, indications, and clinical use of 24 hour esophageal pH monitoring. J Thorac Cardiovasc Surg. 1980, 79: 656-670.
56.
57.
Katz P, Gerson L, Vela M: Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2012, 108: 308-328.CrossRef
58.
Eslick GD, Fass R: Noncardiac chest pain: evaluation and treatment. Gastroenterol Clin North Am. 2003, 32: 531-10.1016/S0889-8553(03)00029-3.CrossRefPubMed
59.
Achem SR, DeVault KR: Recent developments in chest pain of undetermined origin. Curr Gastroenterol Rep. 2000, 2: 201-209. 10.1007/s11894-000-0062-4.CrossRefPubMed
60.
Chambers J, Bass C: Atypical chest pain: looking beyond the heart. QJM. 1998, 91: 239-244. 10.1093/qjmed/91.3.239.CrossRefPubMed
61.
Yelland M, Cayley WE, Vach W: An algorithm for the diagnosis and management of chest pain in primary care. Med Clin North Am. 2010, 94: 349-374. 10.1016/j.mcna.2010.01.011.CrossRefPubMed
62.
Cremonini F, Wise J, Moayyedi P, Talley NJ: Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005, 100: 1226-1232. 10.1111/j.1572-0241.2005.41657.x.CrossRefPubMed
63.
Kahrilas PJ, Hughes N, Howden CW: Response of unexplained chest pain to proton pump inhibitor treatment in patients with and without objective evidence of gastro-oesophageal reflux disease. Gut. 2011, 60: 1473-1478. 10.1136/gut.2011.241307.CrossRefPubMed
64.
Chambers J, Cooke R, Anggiansah A, Owen W: Effect of omeprazole in patients with chest pain and normal coronary anatomy: initial experience. Int J Cardiol. 1998, 65: 51-55. 10.1016/S0167-5273(98)00093-X.CrossRefPubMed
65.
Dekel R, Martinez-Hawthorne SD, Guillen RJ, Fass R: Evaluation of symptom index in identifying gastroesophageal reflux disease-related noncardiac chest pain. J Clin Gastroentero. 2004, 38: 24-29. 10.1097/00004836-200401000-00007.CrossRef
66.
Adamek RJ, Wegener M, Wienbeck M, Pulte T: Esophageal motility disorders and their coexistence with pathological acid reflux in patients with noncardiac chest pain. Scand J Gastroenterol. 1995, 30: 833-838. 10.3109/00365529509101588.CrossRefPubMed
67.
Achem SR, Kolts BE, MacMath T, Richter J, Mohr D, Burton L, Castell DO: Effects of omeprazole versus placebo in treatment of noncardiac chest pain and gastroesophageal reflux. Dig Dis Sci. 1997, 42: 2138-2145. 10.1023/A:1018843223263.CrossRefPubMed
68.
Harbord RM, Deeks JJ, Egger M, Whiting P, Sterne JA: A unification of models for meta-analysis of diagnostic accuracy studies. Biostatistics. 2007, 8: 239-251. 10.1093/biostatistics/kxl004.CrossRefPubMed
69.
Dendukuri N, Schiller I, Joseph L, Pai M: Bayesian meta-analysis of the accuracy of a test for tuberculous pleuritis in the absence of a gold standard reference. Biometrics. 2012, 68: 1285-1293. 10.1111/j.1541-0420.2012.01773.x.CrossRefPubMedPubMedCentral
70.
Leeflang MMG, Rutjes AWS, Reitsma JB, Hooft L, Bossuyt PMM: Variation of a test’s sensitivity and specificity with disease prevalence. Can Med Assoc J. 2013, 185: E537-E544. 10.1503/cmaj.121286.CrossRef
Metadata
Title
Diagnostic indicators of non-cardiovascular chest pain: a systematic review and meta-analysis
Authors
Maria M Wertli
Katrin B Ruchti
Johann Steurer
Ulrike Held
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2013
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-11-239

Other articles of this Issue 1/2013

BMC Medicine 1/2013 Go to the issue

Research article

The contribution of major depression to the global burden of ischemic heart disease: a comparative risk assessment

Commentary

Insights into physical activity and cardiovascular disease risk in young children: IDEFICS study

Erratum

Erratum to: Additional Saturday rehabilitation improves functional independence and quality of life and reduces length of stay: a randomized controlled trial

Research article

Plasminogen activator inhibitor-1 4G/5G polymorphism and retinopathy risk in type 2 diabetes: a meta-analysis

Research article

Anti-ribosomal P protein IgG autoantibodies in patients with systemic lupus erythematosus: diagnostic performance and clinical profile

Minireview

Epigenetic mechanisms in migraine: a promising avenue?